Divisions of Cardiology & Clinical Epidemiology, Centre for Clinical Epidemiology, Jewish General Hospital, Montreal, Quebec, Canada; Division of Vascular Surgery, McGill University, Montreal, Quebec, Canada.
Divisions of Cardiology & Clinical Epidemiology, Centre for Clinical Epidemiology, Jewish General Hospital, Montreal, Quebec, Canada; Division of Internal Medicine, McGill University, Montreal, Quebec, Canada.
JACC Cardiovasc Interv. 2018 Nov 12;11(21):2185-2192. doi: 10.1016/j.jcin.2018.06.037. Epub 2018 Oct 17.
The authors sought to determine whether frail older adults undergoing nonfemoral transcatheter aortic valve replacement (TAVR) procedures had a higher risk of 30-day and 12-month mortality.
Frailty can help predict outcomes and guide therapy in older adults being considered for TAVR. Nonfemoral TAVR procedures are more invasive and impart a greater risk of adverse events, which may be less well tolerated in frail patients, compared with transfemoral TAVR procedures.
This study was a post hoc analysis of the FRAILTY-AVR (Frailty Assessment Before Cardiac Surgery & Transcatheter Interventions) prospective multicenter cohort that consisted of older adults undergoing TAVR from 2012 to 2017. Frailty was assessed using the Essential Frailty Toolset (EFT). Endpoints of interest were 30-day and 12-month all-cause mortality. Interaction tables and multivariable logistic regression models were used to investigate statistical interaction on the additive and multiplicative scales.
The cohort consisted of 723 patients with a mean age of 84 ± 6 years, of which 556 (77%) had femoral access and 167 (23%) had nonfemoral access. In frail patients with EFT scores ≥3 (35%), nonfemoral access was associated with increased 30-day mortality (odds ratio [OR]: 3.91; 95% confidence interval [CI]: 1.48 to 10.31); whereas in nonfrail patients with EFT scores <3 (65%), nonfemoral access had no effect (OR: 1.29; 95% CI: 0.34 to 4.94). There was statistical evidence of interaction between frailty and access site on 30-day mortality on the additive scale (relative excess risk due to interaction = 5.95). Nonfemoral access was associated with increased 1-year mortality in frail patients (OR: 1.98; 95% CI: 1.00 to 3.93) but not in nonfrail patients (OR: 1.83; 95% CI: 0.90 to 3.74), although there was no statistical evidence of interaction.
Frail patients undergoing TAVR via a more invasive nonfemoral access face a substantially higher risk of 30-day mortality, whereas nonfrail older adults tolerate the procedure with a low short-term risk irrespective of access route.
作者旨在确定接受非股动脉经导管主动脉瓣置换术(TAVR)的虚弱老年患者是否有更高的 30 天和 12 个月死亡率风险。
虚弱可以帮助预测结果,并为接受 TAVR 治疗的老年患者提供治疗指导。与经股动脉 TAVR 手术相比,非股动脉 TAVR 手术更具侵袭性,带来更大的不良事件风险,虚弱患者可能更难以耐受。
本研究是 FRAILTY-AVR(心脏手术和经导管介入前虚弱评估)前瞻性多中心队列的事后分析,该队列包括 2012 年至 2017 年间接受 TAVR 的老年患者。使用基本虚弱工具包(EFT)评估虚弱。研究的主要终点为 30 天和 12 个月全因死亡率。交互表和多变量逻辑回归模型用于研究在加性和乘法尺度上的统计交互作用。
该队列共纳入 723 例患者,平均年龄 84±6 岁,其中 556 例(77%)采用股动脉入路,167 例(23%)采用非股动脉入路。在 EFT 评分≥3(35%)的虚弱患者中,非股动脉入路与 30 天死亡率增加相关(比值比 [OR]:3.91;95%置信区间 [CI]:1.48 至 10.31);而在 EFT 评分<3(65%)的非虚弱患者中,非股动脉入路无影响(OR:1.29;95%CI:0.34 至 4.94)。在 30 天死亡率的加性尺度上,虚弱和入路部位之间存在统计学上的交互作用证据(交互归因相对超额风险=5.95)。非股动脉入路与虚弱患者的 1 年死亡率增加相关(OR:1.98;95%CI:1.00 至 3.93),但与非虚弱患者无关(OR:1.83;95%CI:0.90 至 3.74),尽管没有统计学上的交互作用证据。
接受更具侵袭性的非股动脉 TAVR 手术的虚弱患者 30 天死亡率风险显著增加,而无论入路途径如何,非虚弱的老年患者都能耐受该手术,短期风险较低。